5 Stocks Targeted By Short Sellers Recently

In this piece, we will take a look at five stocks targeted by short sellers recently. For more stocks, head on over to 10 Stocks Targeted By Short Sellers Recently.

5. Altamira Therapeutics Ltd. (NASDAQ:CYTO)

Change In Short Interest Percentage: 12.71

Altamira Therapeutics Ltd. (NASDAQ:CYTO) is a biotechnology company that is headquartered in Hamilton, Bermuda. The firm develops treatments for a variety of illnesses such as vertigo, hearing loss, tinnitus, viruses, and allergies. As of March 14, 2023, Altamira Therapeutics Ltd. (NASDAQ:CYTO)’s short interest percentage stood at 13.73% from an earlier 1.02%. Seems like something’s up for sure. The total number of short interest shares is 323,120 shares, for a 0.2 short ratio and up from February’s 14,940 shares.

4. Unicycive Therapeutics, Inc. (NASDAQ:UNCY)

Change In Short Interest Percentage: 13.45

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) is an American biotechnology company that is headquartered in Los Altos, California. The firm primarily develops treatments for people with kidney problems such as those undergoing dialysis and with kidney injuries. Like Altamira, Unicycive Therapeutics, Inc. (NASDAQ:UNCY)’s short interest percentage has jumped rapidly between February and March 2023, currently sitting at 15.05% from the earlier 1.60%. Total shares short are a whopping 1.39 million up from the previous 180,340.

As of December 2022, one of the 943 hedge funds part of Insider Monkey’s database had invested in Unicycive Therapeutics, Inc. (NASDAQ:UNCY). This lone investor is Wilmot B. Harkey and Daniel Mack’s Nantahala Capital Management which owns 647,416 shares that are worth $349,605.

3. Secoo Holding Limited (NASDAQ:SECO)

Change In Short Interest Percentage: 17.81

Secoo Holding Limited (NASDAQ:SECO) is a Chinese internet company that is headquartered in Beijing. The firm operates an online retail platform that sells several products such as home accessories, watches, and jewelry from branded companies. As of March 15, 2023, there were 83,865 shares sold short, up from 29,442 at the end of February.

After digging through 943 hedge funds for their December quarter of 2022 investments, Insider Monkey found out that one had held a share in the firm. This investor is Jim Simons’ Renaissance Technologies which owns 27,000 shares that are worth $14,590.

2. Tenax Therapeutics, Inc. (NASDAQ:TENX)

Change In Short Interest Percentage: 18.71

Tenax Therapeutics, Inc. (NASDAQ:TENX) is a biotechnology firm headquartered in Chapel Hill, North Carolina. It develops treatments for people suffering from complications of heart disease. As of March 15, 2023, 2.16 million shares are short, up from the prior month’s 363,420.

By the end of last year’s fourth quarter, just one of the 943 hedge funds polled by Insider Monkey had bought Tenax Therapeutics, Inc. (NASDAQ:TENX)’s shares. The lone investor is Jim Simons’ Renaissance Technologies which owns 63,362 shares that are worth $7,000.

1. Ensysce Biosciences, Inc. (NASDAQ:ENSC)

Change In Short Interest Percentage: 31.66

Ensysce Biosciences, Inc. (NASDAQ:ENSC) is an American biotechnology firm that develops treatments for opioid abuse and addiction. Its short interest is 48,390 shares up from February’s 22,930.

Two of the 943 hedge funds surveyed by Insider Monkey for their Q4 2022 investments had held a stake in the firm.

Disclosure: None. You can also take a look at 14 Cheap Quarterly Dividend Stocks to Buy and 13 Best Medical Stocks To Invest In.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter